Medical Communications
NICE recommends new life-extending treatment for rare form of gastroesophageal cancer
November 25, 2022 Medical Communications
Clinical evidence shows Bristol Myers Squibb’s nivolumab, with chemotherapy, could help extend the lives of patients with untreated HER2-negative, advanced …
New malaria vaccine demonstrates high efficacy
September 9, 2022 Medical Communications
A new malaria vaccine could be pivotal in the fight against the deadly disease. This vaccine has been developed …
Self-sterilising plastic kills viruses such as COVID-19
September 9, 2022 Medical Communications
Scientists from Queen’s University Belfast have developed a virus-killing plastic that could make it harder for bugs, such as COVID-19, …
GSK awarded UNICEF contract for malaria vaccine
August 19, 2022 Medical Communications
In 2020, nearly half a million children died from malaria in Africa alone, a rate of one child death per …
New COVID-19 study from The Lancet Psychiatry journal shows higher risk of brain fog
August 19, 2022 Medical Communications
The study also found that adults faced an increased risk of anxiety and depression, but this subsided within two months …
Home-based brain stimulation study on stroke survivors finds mixed results
August 19, 2022 Medical Communications
26 stroke survivors were given four weeks of remotely supervised transcranial direct current stimulation (RS-tDCS) in an at-home cognitive rehabilitation …
Jazz Pharmaceuticals takes groundbreaking epilepsy drug Epidiolex for adolescents into phase III trial
August 19, 2022 Medical Communications
The phase III trials will assess Epidiolex over 14 weeks in a randomised, double-blind, placebo-controlled study, enrolling paediatric patients aged …
MHRA grants marketing authorisation for Novartis’ Pluvicto
August 12, 2022 Medical Communications
Radioligand therapy is used to treat patients with advanced prostate cancer
Bristol Myers Squibb and GentiBio in $1.9bn deal to develop inflammatory bowel disease therapies
August 12, 2022 Medical Communications
BMS will have the right to develop and advance up to three of the resulting programmes into clinical trials
Blood tests taken within 24 hours of a traumatic brain injury can predict whether a patient will die, or survive with serious disability
August 12, 2022 Medical Communications
The tests’ results are available within minutes and will be useful in helping trauma ward staff and surgeons to decide …
ONS figures show rapid decrease in people with higher COVID-19 antibody figures
August 12, 2022 Medical Communications
The amount of UK residents with higher levels of COVID-19 antibodies is falling, ONS statistics show.
F2G announce development and commercialisation for rare antifungal treatment
August 5, 2022 Medical Communications
F2G, a clinical-stage biopharmaceutical company, has announced that it can now soon bring a fourth antifungal class to the market. …
Societal CDMO wins tech transfer and production contract for HIV drug candidate
August 5, 2022 Medical Communications
Societal CDMO, a contract development and manufacturing organisation (CDMO) has been selected to provide CDMO services to support the ongoing …
NICE recommend new early targeted treatment for breast cancer
July 22, 2022 Medical Communications
Abemaciclib (Verzenios) has been approved by the NICE to treat some people with breast cancer that has a high-risk of …
£70 million in fines for pharma firms that overcharged NHS
July 22, 2022 Medical Communications
The CMA has found that Pfizer and Flynn charged unfairly high prices for phenytoin sodium capsules for over four years, …
Latest content
October 26, 2026
